SPCPB16A4.02c Antibody

What is SPCPB16A4.02c antibody and what cellular components does it target?

SPCPB16A4.02c antibody targets proteins involved in chromosome segregation during mitosis, similar to other kinetochore-related antibodies like SPC24. These antibodies recognize components that are essential for proper chromosome attachment to spindle microtubules and accurate cell division. The targeted proteins are typically localized to the chromosome, nucleus, centromere, and kinetochore cellular compartments . Understanding these localizations is crucial for experimental design, as different fixation and permeabilization methods may be required to access nuclear versus cytoplasmic antigens.

What are the recommended applications for SPCPB16A4.02c antibody?

Based on antibody characterization data from similar research tools, SPCPB16A4.02c antibody is primarily recommended for Western blotting and ELISA applications. For Western blotting, a dilution range of 1:1000 to 1:5000 is typically optimal, though this should be empirically determined for each experimental setup . Before using this antibody in critical experiments, validation through multiple techniques is strongly recommended to ensure specificity and reproducibility of results, following the five pillars of antibody validation as outlined by the International Working Group for Antibody Validation .

How should SPCPB16A4.02c antibody be stored to maintain its activity?

For optimal preservation of antibody activity, store SPCPB16A4.02c antibody at -20°C in appropriate buffer conditions (typically PBS with stabilizers such as 0.05% proclin300 and 50% glycerol at pH 7.3). Avoid repeated freeze-thaw cycles as these can significantly degrade antibody performance . For working solutions, small aliquots should be prepared to minimize freeze-thaw cycles, and these can typically be stored at 4°C for up to two weeks without significant loss of activity.

What controls should be included when using SPCPB16A4.02c antibody?

Robust experimental design with appropriate controls is essential for antibody-based research. Based on current best practices for antibody validation, researchers should include:

• Positive controls - Cell lines or tissues known to express the target protein (e.g., HeLa cells for similar kinetochore proteins)

• Negative controls - Samples where the target protein is absent or depleted

• Genetic controls - Using knockout or knockdown techniques to verify antibody specificity

• Isotype controls - Using non-specific antibodies of the same isotype to identify background binding

The importance of these controls cannot be overstated, as inadequate antibody characterization is a significant contributor to irreproducible research findings .

How can I validate the specificity of SPCPB16A4.02c antibody?

Following the "five pillars" approach to antibody validation, researchers should employ multiple strategies to confirm specificity:

This multi-faceted approach significantly increases confidence in antibody specificity and experimental results .

What are the potential cross-reactivity issues with SPCPB16A4.02c antibody?

When working with antibodies targeting kinetochore proteins in fission yeast S. pombe, potential cross-reactivity with similar proteins in the experimental system must be considered. Sequence similarity between target proteins across species can lead to unexpected binding. For example, when working with antibodies in S. pombe, researchers should be aware of potential interactions with structural homologs . To identify potential cross-reactivity:

• Perform Western blot analysis using whole cell lysates from relevant model organisms

• Compare the observed banding pattern with the predicted molecular weight (calculated MW for similar proteins is typically around 22kDa, though observed MW may differ due to post-translational modifications)

• Consider immunoprecipitation followed by mass spectrometry to identify all proteins recognized by the antibody

How can I optimize immunoprecipitation protocols with SPCPB16A4.02c antibody?

For successful immunoprecipitation of chromosome-associated proteins:

• Cell lysis optimization: Use nuclear extraction buffers containing 0.1-0.5% NP-40 or similar non-ionic detergents to solubilize nuclear membrane while preserving protein-protein interactions

• Antibody coupling: Consider covalently coupling the antibody to protein A/G beads using crosslinkers like BS3 or DMP to prevent antibody contamination in the eluted sample

• Washing stringency: Balance between removing non-specific interactions (higher stringency) and maintaining specific but weak interactions (lower stringency)

• Elution conditions: For downstream applications requiring native proteins, consider competitive elution with excess immunizing peptide rather than denaturing elution

For proteins like those in the NDC80 complex, which form part of larger protein assemblies, gentler extraction conditions may be necessary to maintain complex integrity during immunoprecipitation .

What are the considerations for using SPCPB16A4.02c antibody in chromatin immunoprecipitation (ChIP)?

While kinetochore proteins aren't typically targets for ChIP, similar methodological considerations apply when working with any DNA-associated proteins:

• Crosslinking optimization: Different proteins require different crosslinking conditions. For kinetochore-associated proteins, standard formaldehyde crosslinking (1%, 10 minutes) is a reasonable starting point

• Sonication parameters: Optimize sonication to generate chromatin fragments of 200-500bp without denaturing your target protein

• Antibody amount: Titrate antibody to determine optimal concentration, typically 2-5μg per ChIP reaction

• Washing buffers: Progressively increase salt concentration in washing buffers to reduce non-specific binding

When working with S. pombe cells (as might be relevant for SPCPB16A4.02c antibody research), cell wall disruption using enzymatic methods (zymolyase treatment) prior to sonication is critical for efficient chromatin preparation .

How can I apply SPCPB16A4.02c antibody in super-resolution microscopy studies?

For high-resolution imaging of kinetochore structures:

• Fixation optimization: Test different fixation protocols (paraformaldehyde, methanol, or combinations) to preserve antigen accessibility while maintaining cellular architecture

• Secondary antibody selection: Choose secondary antibodies conjugated to fluorophores compatible with super-resolution techniques (e.g., Alexa Fluor 647 for STORM)

• Sample mounting: Use mounting media with appropriate refractive index and anti-fade properties

• Validation of structures: Compare observed structures with known kinetochore architecture to confirm specificity

Since kinetochore components like those in the NDC80 complex have precise spatial organization, super-resolution techniques can provide valuable insights into their structural arrangement during different cell cycle phases .

What are common causes of false positive or false negative results when using SPCPB16A4.02c antibody?

The reproducibility crisis in antibody-based research highlights the importance of thorough validation and careful experimental design to avoid both false positives and negatives .

How can I address batch-to-batch variability in SPCPB16A4.02c antibody performance?

Batch-to-batch variability is a significant challenge in antibody research. To mitigate this:

• Record lot numbers: Always document the specific lot used for each experiment

• Perform lot validation: Test each new lot against a reference lot using your standard assays

• Purchase sufficient quantity: When possible, purchase enough of a validated lot to complete an entire study

• Create standard samples: Generate reference samples that can be used to calibrate new antibody lots

The International Working Group for Antibody Validation recommends standardized reporting of antibody validation data to address reproducibility issues stemming from batch variation .

What strategies can I use to enhance signal detection with SPCPB16A4.02c antibody in low-expression systems?

For detecting proteins with low expression levels:

• Signal amplification methods:

  • Tyramine signal amplification (TSA) can increase fluorescence signal 10-100 fold

  • Polymer-based detection systems for enhanced sensitivity in IHC/ICC

• Sample enrichment:

  • Perform subcellular fractionation to concentrate the compartment where the target is located

  • Use immunoprecipitation prior to Western blotting for target enrichment

• Detection optimization:

  • For Western blotting, use high-sensitivity substrates (e.g., femto-level ECL substrates)

  • Increase primary antibody incubation time (overnight at 4°C)

  • Optimize blocking to reduce background while preserving specific signal

Similar approaches have been successfully applied to detect low-abundance components of protein complexes in mitosis research .

How does phosphorylation affect epitope recognition by SPCPB16A4.02c antibody?

Post-translational modifications, particularly phosphorylation, can significantly impact antibody recognition. Kinetochore proteins are heavily regulated by phosphorylation during mitosis, which can either mask or expose antibody epitopes:

• Modification-sensitive epitopes: If the antibody epitope contains potential phosphorylation sites, recognition may be blocked when the protein is phosphorylated

• Conformational changes: Phosphorylation distant from the epitope can still affect recognition through induced conformational changes

• Experimental approaches:

  • Compare antibody reactivity before and after phosphatase treatment

  • Use phospho-specific antibodies in parallel to determine phosphorylation status

  • Consider the cell cycle stage in your experimental design, as kinetochore protein phosphorylation varies throughout mitosis

When working with mitotic proteins similar to those targeted by SPCPB16A4.02c antibody, these considerations become particularly important as phosphorylation cascades play critical roles in regulating kinetochore assembly and function .

What are the implications of protein complex formation for SPCPB16A4.02c antibody binding?

Kinetochore proteins typically function as components of larger protein complexes. This has several implications for antibody-based detection:

• Epitope accessibility: Complex formation may mask epitopes that are accessible in the monomeric protein

• Extraction conditions: Harsh detergents may improve extraction efficiency but disrupt complexes

• Co-immunoprecipitation potential: The antibody may pull down entire complexes, offering opportunities to study protein-protein interactions

• Functional assays: Consider whether antibody binding disrupts complex formation or function when designing functional studies

Similar to SPC24, which functions as part of the NDC80 complex, SPCPB16A4.02c likely participates in protein complexes involved in kinetochore function, making these considerations particularly relevant .

How can I integrate SPCPB16A4.02c antibody-based approaches with emerging technologies?

To maximize research impact, consider integrating antibody-based approaches with cutting-edge technologies:

• Proximity labeling: Combine antibody-based protein detection with BioID or APEX2 proximity labeling to identify neighboring proteins in the native cellular context

• Live-cell imaging: Correlate antibody-based fixed cell observations with live-cell imaging using fluorescent protein fusions

• Single-cell analyses: Integrate antibody-based protein quantification with single-cell transcriptomics for multi-omic analyses

• Cryo-electron microscopy: Use antibody labeling to identify components within larger macromolecular complexes visualized by cryo-EM

The SC27 antibody research demonstrates how antibody characterization technologies can lead to therapeutic applications, highlighting the translational potential of fundamental antibody research .